Injective

**November Highlights for Injective:** - Celebrated 3rd mainnet anniversary (launched Nov 8, 2021) - Hosted first-ever Injective Summit with 21,000+ attendees featuring Agora Finance, Monad, Binance - Launched iAgent, an AI-powered SDK for creating on-chain AI agents - Released $150M ecosystem fund **Key Metrics:** - $1.4B+ monthly DEX trading volume - 45,915 INJ ($1.37M) burned this month - 1.2B total on-chain transactions processed Eric Chen, CEO of Injective Labs, shared upcoming developments during the summit.

21Shares, a leading issuer of crypto Exchange Traded Products (ETPs), has introduced AINJ, the Injective Staking ETP. This innovative product offers exposure to INJ through major traditional finance exchanges and brokerages while also capturing staking rewards. AINJ is already supported by prominent financial institutions such as Interactive Brokers, Saxo Bank, Swissquote, and eToro. 21Shares, which has been at the forefront of Bitcoin ETF efforts alongside Cathie Wood's Ark Invest, brings significant experience and reputation to this new offering. The launch of AINJ represents a crucial step in Injective's strategy to integrate with traditional markets and institutions.

The first Injective Builder House took place in Brussels during EthCC, marking a significant milestone for the Injective community. The full-day event brought together industry leaders, developers, and community members from across the Injective ecosystem. The event commenced with a keynote address by Injective Labs co-founder and CEO Eric Chen. This gathering served as a platform for networking and collaboration within the Injective community, highlighting the growing importance of builder-focused events in the blockchain industry.